Skip to main content
    L

    Lifestance Health Group Inc (LFST)

    Official site

    HEALTHCARE • MEDICAL CARE FACILITIES • NASDAQ

    $12.52
    +0.20 (+1.62%)

    Market Cap: $4.76B

    Last updated: Oct 16, 2026 at 1:55 PM ET

    Earnings

    Performance (10Y)

    Beat Rate
    57%(12/21)
    Avg Surprise
    -55.42%
    Streak
    3 Q

    Upcoming Estimates

    Period ending Sep 30, 2026
    EPS Consensus$0.08
    Range$0.07 - $0.10
    5 analysts
    EPS RevisionsNo revisions (7d)
    5
    0
    30d
    EPS Estimate DriftChange to current
    90d ago$0.07+14.0%
    60d ago$0.07+14.0%
    30d ago$0.10-16.0%
    7d ago$0.10-16.0%
    Current$0.08
    Revenue Consensus
    $432M
    Range$426M - $437M
    9 analysts
    Period ending Dec 31, 2026
    EPS Consensus$0.13
    Range$0.09 - $0.16
    5 analysts
    Revenue Consensus
    $476M
    Range$468M - $489M
    10 analysts
    PeriodReportedEst.SurpriseB/MYoY
    Dec 26EST
    		-$0.13---
    Sep 26EST
    		-$0.08---
    Jun 26
    Reported Aug 6
    		$0.06$0.03+100.00%Beat+700.0%
    Mar 26
    Reported May 7
    		$0.07$0.06+16.67%Beat+40.0%
    Dec 25
    Reported Feb 25
    		$0.09$0.05+64.38%Beat+986.0%
    Sep 25
    Reported Nov 6
    		$0.01N/A-75.00%Miss-66.7%
    Jun 25
    Reported Aug 7
    		$-0.01N/A+66.67%Beat-200.0%
    Mar 25
    Reported May 7
    		$0.05$0.01+400.00%Beat+183.3%
    Dec 24
    Reported Feb 27
    		$-0.01N/A+73.89%Beat+91.7%
    Sep 24
    Reported Nov 7
    		$0.03$-0.01+400.00%Beat+250.0%
    Jun 24
    Reported Aug 8
    		$0.01$-0.01+200.00%Beat+133.3%
    Mar 24
    Reported May 9
    		$-0.06$-0.01-500.00%Miss-100.0%
    Dec 23
    Reported Feb 28
    		$-0.12$-0.09-33.33%Miss+7.7%
    Sep 23
    Reported Nov 8
    		$-0.02$-0.02+0.00%Beat+0.0%
    Jun 23
    Reported Aug 9
    		$-0.03$-0.02-50.00%Miss+0.0%
    Mar 23
    Reported May 10
    		$-0.03$-0.03+0.00%Beat-50.0%
    Dec 22
    Reported Mar 8
    		$-0.13$-0.13+0.00%Beat+60.6%
    Sep 22
    Reported Nov 8
    		$-0.02$-0.01-100.00%Miss+94.3%
    Jun 22
    Reported Aug 9
    		$-0.03$-0.02-50.00%Miss+50.0%
    Mar 22
    Reported May 9
    		$-0.02$-0.04+50.00%Beat+80.0%
    Dec 21
    Reported Mar 10
    		$-0.33$-0.21-57.14%Miss-658.6%
    Sep 21
    Reported Nov 8
    		$-0.35$-0.02-1650.00%Miss-
    Jun 21
    Reported Aug 11
    		$-0.06$-0.05-20.00%Miss-
    Mar 21
    Reported Apr 12
    		$-0.10$0.00N/AMiss-
    Dec 20
    Reported Mar 31
    		$-0.04$0.00N/AMiss-

    Key Metrics

    Valuation
    P/E Ratio54.77EV/EBITDA36.41x
    Price/FCF27.61xFCF Yield3.62%
    Profitability
    Profit Margin3.19%Operating Margin7.25%
    ROE3.43%ROIC3.36%
    Financial Health
    Debt/Equity0.18xInterest Coverage7.63x
    Current Ratio1.38xQuick Ratio1.38x
    Trading Statistics
    Beta1.24Avg Volume4.62M
    52-Week High$13.5652-Week Low$4.77

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$12.20
    SMA 20$12.19
    SMA 50$12.28
    SMA 200$9.01
    EMA 10$12.28
    EMA 20$12.27
    EMA 50$11.98
    EMA 200$9.63

    MACD

    Line: 0.02Signal: -0.02Hist: 0.04

    ADX

    ADX: 14.7+DI: 21.8-DI: 19.2

    Aroon & PSAR

    Aroon Up12.0
    Aroon Down68.0
    PSAR$11.70

    Bollinger Bands

    Upper Band$12.79
    Lower Band$11.59
    %B Position983%(Upper)
    Band Width0.77

    RSI (14-Day)

    Neutral
    56.3

    Momentum Oscillators

    Stoch %K83.8
    Stoch %D75.9
    Williams %R-13.2
    ROC (10d)4.1%
    Momentum0.49
    CCI (20d)54.2
    MFI (14d)37.1

    Volatility Measures

    ATR (14d)$0.40(3.2%)
    StdDev (20d)0.30
    Hist Vol26.0%(Moderate)

    Volume Flow

    VWAP$12.40
    OBV100.7M
    AD Line70.4M
    CMF (20d)0.043

    Volume Metrics

    Avg Vol (20d)4.5M
    Vol Ratio0.6x
    VWMA (20d)$12.24

    Pivot Points

    R3$12.96
    R2$12.82
    R1$12.57
    Pivot Point$12.43
    S1$12.18
    S2$12.04
    S3$11.79

    Advanced Oscillators

    TSI1.13
    Ultimate Osc58.1
    KST-34.52

    Financial Data

    QuarterJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
    Total Revenue$435.35M$403.48M$382.19M$363.81M$345.31M$332.97M$325.48M$312.72M$312.33M$300.44M$280.60M$262.89M
    Cost of Revenue$0$0$255.90M$0$0$0$216.04M$0$0$0$197.29M$0
    Gross Profit$435.35M$403.48M$382.19M$363.81M$345.31M$332.97M$325.48M$312.72M$312.33M$300.44M$280.60M$262.89M
    Operating Expenses$404.70M$381.19M$364.11M$356.40M$348.26M$331.37M$324.42M$312.68M$328.28M$317.21M$312.87M$337.25M
    R&D$0$0$0$0$0$0$0$0$0$0$0$0
    SG&A$108.14M$100.33M$94.78M$95.61M$97.38M$94.43M$93.71M$85.27M$95.15M$88.93M$-462,912,000$317.63M
    Operating Income$30.65M$22.28M$18.08M$7.41M$-2,950,000$1.60M$1.06M$47,000$-15,947,000$-16,772,000$-32,271,000$-74,357,000
    Interest Income$0$0$0$0$0$0$0$0$0$0$0$0
    Interest Expense$2.63M$1.79M$2.88M$2.81M$2.90M$3.07M$9.40M$5.41M$5.82M$5.90M$5.53M$5.48M
    Income Before Tax$27.46M$19.76M$15.20M$4.57M$-5,942,000$-1,470,000$-8,876,000$-5,382,000$-22,621,000$-20,734,000$-38,316,000$-77,968,000
    Income Tax Expense$3.85M$5.52M$3.54M$3.50M$-2,151,000$-2,179,000$-1,764,000$575,000$656,000$363,000$6.64M$-16,385,000
    Net Income$23.61M$14.24M$11.67M$1.08M$-3,791,000$709,000$-7,112,000$-5,957,000$-23,277,000$-21,097,000$-44,959,000$-61,583,000
    EBITDA$44.68M$35.12M$31.77M$21.20M$11.22M$15.61M$15.59M$15.57M$2.22M$8.16M$-10,058,000$-52,354,000
    EBIT$30.18M$21.55M$18.08M$7.39M$-3,042,000$1.60M$520,000$31,000$-16,798,000$-14,831,000$-32,784,000$-72,491,000
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about LFST

    News

    LifeStance to Host Third Quarter 2026 Earnings Conference Call on November 5, 2026

    LifeStance Health Group, Inc. (NASDAQ: LFST) will release its third-quarter 2026 earnings before the market opens on Thursday, November 5...

    The Manila Times•10/16/26•Neutral

    LifeStance to Host Third Quarter 2026 Earnings Conference Call on November 5, 2026

    LifeStance Health Group, Inc. (NASDAQ: LFST) will release its third quarter 2026 earnings before the market opens on Thursday, November 5...

    Yahoo Finance•10/15/26•Neutral

    LifeStance Health Group Q3FY26 Results: Earnings call scheduled for Nov 5

    LifeStance Health Group is set to release its third-quarter fiscal year 2026 earnings before market open on November 5, 2026, followed by a live conference call at 8:30 AM ET. The company...

    scanx.trade•10/15/26•Neutral

    LifeStance to Host Third Quarter 2026 Earnings Conference Call on November 5, 2026

    LifeStance Health Group, Inc. (NASDAQ: LFST) announced it will release its third quarter 2026 earnings before the market opens on Thursday, November 5...

    GlobeNewswire•10/15/26•Neutral

    What Is Drawing Fresh Attention To LifeStance Health Group (LFST)?

    LifeStance Health Group (LFST) has recently gained attention after a Zacks upgrade to a Rank #2 (Buy), driven by recent earnings estimate revisions. Despite short-term share price choppiness...

    Simply Wall Street•10/14/26•Somewhat-Bullish

    LFST Valuation and Fair Value

    P/E
    54.8x
    Forward P/E
    52.6x
    EV/EBITDA
    36.4x
    P/FCF
    27.6x
    P/B
    3.3x
    See GNG's fair value

    LFST Profitability: Margins, ROIC and FCF

    Gross margin
    100.0%
    Operating margin
    7.2%
    Net margin
    3.2%
    ROIC
    3.4%
    ROE
    3.4%
    FCF margin
    11.0%
    FCF yield
    3.6%

    LFST Competitors

    CompanyTicker
    Concentra Group Holdings Parent, Inc.CON
    Option Care Health IncOPCH
    Scholar Rock Holding CorpSRRK
    Amicus Therapeutics IncFOLD
    Crispr Therapeutics AGCRSP
    Akero Therapeutics IncAKRO
    Grifols SA ADRGRFS
    Diversified Healthcare TrustDHCNL

    Sector: Healthcare

    LFST Analyst Ratings

    Consensus
    Buy
    Analysts
    11
    Strong Buy
    2
    Buy
    7
    Hold
    2
    Sell
    0
    Strong Sell
    0

    LFST Bull Case vs Bear Case

    Bull case

    • LFST beat EPS estimates in 87.5% of its last 8 reported quarters.
    • LFST grew quarterly revenue 26.1% year over year.
    • 81.8% of LFST's analyst ratings are Buy or Strong Buy.

    Bear case

    • LFST trades at 54.8x trailing earnings.

    LFST Earnings: Beat Rate and Next Report

    Beat rate
    7 of 8 quarters (87.5%)
    Average surprise
    130.8%
    EPS estimate (fiscal period ending Sep 30, 2026)
    $0.08
    Estimate revisions (30 days, fiscal period ending Sep 30, 2026)
    5 up, 0 down

    Frequently Asked Questions About LFST

    Does LFST pay dividends?

    Lifestance Health Group Inc (LFST) does not currently pay a regular dividend.

    What is LFST's P/E ratio?

    Lifestance Health Group Inc has a price-to-earnings (P/E) ratio of 54.77.

    What is LFST's market cap?

    Lifestance Health Group Inc (LFST) has a market capitalization of $4.76B with a current stock price of $12.52.

    Related stocks

    Sector: Healthcare

    All stocks starting with L

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In